martes, 6 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 2, 2026

Uber: From Cash Burner to Cash-Flow Utility

View original at finance.yahoo.com
Uber: From Cash Burner to Cash-Flow Utility This article first appeared on GuruFocus. It has been a fascinating journey watching Uber Technologies evolve from a cash-incinerating startup into what I now consider a dominant, cash-generating utility…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Rating Uber stock a Buy with high-conviction accumulation zone between $70 and $80, with 12 to 18 month price target at $110, implying roughly 35-40% upside

    80% confidence
  • Uber expects to grow Gross Bookings in the mid-teens and EBITDA in the high-30s to 40% range

    80% confidence
  • Uber accumulated roughly $32 billion in operating losses prior to mid-2023

    80% confidence
  • Restaurant delivery represents a $2 trillion Total Addressable Market while general commerce represents a $12 trillion TAM

    80% confidence
  • Uber operates the largest mobility and delivery network on the planet with nearly 190 million monthly active platform consumers across 70 countries

    80% confidence
  • Uber has scaled its advertising business to over $1 billion in annualized revenue

    80% confidence
  • Instant Retail vertical is running at a $12 billion annualized gross bookings rate

    80% confidence
  • Uber is positioning itself to be the essential infrastructure to the autonomous future rather than an inevitable loser in the robotaxi wars

    80% confidence
  • Management describes the gap between Adjusted EBITDA and operating income as due to one-off or non-recurring items, specifically legal reserves, regulatory settlements, and volatility in insurance reserves

    80% confidence
  • Suburban markets are growing 1.5 to 3 times faster than core metro areas

    80% confidence
  • Waymo vehicles on Uber network in Phoenix and San Francisco are seeing utilization rates significantly higher than human-driven cars

    80% confidence
  • In Uber's top 10 markets, only about 15% of the adult population uses the service

    80% confidence
  • Only about 20% of Uber's user base utilizes both the Mobility and Delivery platforms, but users who engage with both verticals spend roughly three times more than single-platform users

    80% confidence

Data points we hold from this source

Uber Technologies · instant retail gross bookings12 billion_USD
Uber Technologies · adjusted ebitda2.3 billion_USD
Uber Technologies · adjusted ebitda growth33 percent
Uber Technologies · advertising revenue1 billion_USD
Uber Technologies · autonomous vehicle partnerships14 partnerships
Uber Technologies · cross platform usage rate20 percent
Uber Technologies · daily trips38 million
Uber Technologies · deferred tax asset release4 billion_USD
Uber Technologies · delivery bookings growth24 percent
Uber Technologies · free cash flow9 billion_USD
Uber Technologies · gross bookings growth21 percent
Uber Technologies · market penetration top 10 markets15 percent
Uber Technologies · monthly active platform consumers190 million
Uber Technologies · net income16 billion_USD
Uber Technologies · operating countries70 countries
Uber Technologies · operating income1.1 billion_USD
Uber Technologies · revenue13.5 billion_USD
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com
Uber: From Cash Burner to Cash-Flow Utility — Source | Via News | es.VIA.NEWS